Rahner R, Eckhardt A, Duchêne M, Domdey H, von Specht B U
Chirurgische Universitäts-Klinik, Freiburg, FR Germany.
Infection. 1990 Jul-Aug;18(4):242-5. doi: 10.1007/BF01643398.
Two monoclonal antibodies (mAbs) designated 2A1 and 6A4 which had been shown to be directed against Pseudomonas aeruginosa outer membrane lipoprotein I were tested in cyclophosphamide treated mice for their protective ability against P. aeruginosa infection. Pretreatment of mice with either 2 mg of 2A1 or 4 mg of 6A4 in combination with lethally irradiated human leucocytes reduced the mortality after subsequent subcutaneous injection of 100 living P. aeruginosa organisms to 50% of the controls. Without leucocytes only mAb 2A1 (isotype IgG2b) showed protection (47%). Irradiated leucocytes alone without mAb did not protect the mice significantly from fatal P. aeruginosa infection.
两种单克隆抗体(mAb),即2A1和6A4,已证明它们针对铜绿假单胞菌外膜脂蛋白I。在环磷酰胺处理的小鼠中测试了它们对铜绿假单胞菌感染的保护能力。用2毫克2A1或4毫克6A4与经致死剂量照射的人白细胞联合预处理小鼠,可将随后皮下注射100个活的铜绿假单胞菌后的死亡率降低至对照组的50%。在没有白细胞的情况下,只有单克隆抗体2A1(同种型IgG2b)显示出保护作用(47%)。没有单克隆抗体的经照射白细胞本身并不能显著保护小鼠免受致命的铜绿假单胞菌感染。